PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy Article Swipe
Daniel Davies
,
Shraddha Kamdar
,
Richard Woolf
,
Iva Zlatareva
,
Maria Luisa Iannitto
,
Cienne Morton
,
Yasmin Haque
,
H Martin
,
Dhruva Biswas
,
Susan Ndagire
,
Martina Munonyara
,
Cheryl Gillett
,
Olga O’Neill
,
Oliver Nussbaumer
,
Adrian Hayday
,
Yin Wu
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1038/s43018-023-00690-0
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1038/s43018-023-00690-0
Related Topics
Concepts
Cytotoxic T cell
Cancer immunotherapy
Melanoma
Cancer research
Immunotherapy
CD8
Cancer cell
Effector
Cancer
T-cell receptor
PD-L1
Transcriptome
Biology
T cell
Immune checkpoint
Antigen
Cell biology
Immunology
Immune system
Gene
Gene expression
Genetics
In vitro
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s43018-023-00690-0
- https://www.nature.com/articles/s43018-023-00690-0.pdf
- OA Status
- hybrid
- Cited By
- 38
- References
- 78
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390538897
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390538897Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s43018-023-00690-0Digital Object Identifier
- Title
-
PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-03Full publication date if available
- Authors
-
Daniel Davies, Shraddha Kamdar, Richard Woolf, Iva Zlatareva, Maria Luisa Iannitto, Cienne Morton, Yasmin Haque, H Martin, Dhruva Biswas, Susan Ndagire, Martina Munonyara, Cheryl Gillett, Olga O’Neill, Oliver Nussbaumer, Adrian Hayday, Yin WuList of authors in order
- Landing page
-
https://doi.org/10.1038/s43018-023-00690-0Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s43018-023-00690-0.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s43018-023-00690-0.pdfDirect OA link when available
- Concepts
-
Cytotoxic T cell, Cancer immunotherapy, Melanoma, Cancer research, Immunotherapy, CD8, Cancer cell, Effector, Cancer, T-cell receptor, PD-L1, Transcriptome, Biology, T cell, Immune checkpoint, Antigen, Cell biology, Immunology, Immune system, Gene, Gene expression, Genetics, In vitroTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
38Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 22, 2024: 15Per-year citation counts (last 5 years)
- References (count)
-
78Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390538897 |
|---|---|
| doi | https://doi.org/10.1038/s43018-023-00690-0 |
| ids.doi | https://doi.org/10.1038/s43018-023-00690-0 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38172341 |
| ids.openalex | https://openalex.org/W4390538897 |
| fwci | 17.71132768 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000378 |
| mesh[1].descriptor_ui | D016176 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | metabolism |
| mesh[1].descriptor_name | T-Lymphocyte Subsets |
| mesh[2].qualifier_ui | Q000378 |
| mesh[2].descriptor_ui | D061026 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | metabolism |
| mesh[2].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[3].qualifier_ui | Q000378 |
| mesh[3].descriptor_ui | D016692 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | metabolism |
| mesh[3].descriptor_name | Receptors, Antigen, T-Cell, gamma-delta |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D020869 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Gene Expression Profiling |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D007167 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Immunotherapy |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D009369 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Neoplasms |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | Q000378 |
| mesh[8].descriptor_ui | D016176 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | metabolism |
| mesh[8].descriptor_name | T-Lymphocyte Subsets |
| mesh[9].qualifier_ui | Q000378 |
| mesh[9].descriptor_ui | D061026 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | metabolism |
| mesh[9].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D016692 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | Receptors, Antigen, T-Cell, gamma-delta |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D020869 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Gene Expression Profiling |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D007167 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Immunotherapy |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D009369 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Neoplasms |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D006801 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Humans |
| mesh[15].qualifier_ui | Q000378 |
| mesh[15].descriptor_ui | D016176 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | metabolism |
| mesh[15].descriptor_name | T-Lymphocyte Subsets |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D061026 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[17].qualifier_ui | Q000378 |
| mesh[17].descriptor_ui | D016692 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | metabolism |
| mesh[17].descriptor_name | Receptors, Antigen, T-Cell, gamma-delta |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D020869 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Gene Expression Profiling |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D007167 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Immunotherapy |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D009369 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Neoplasms |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | Q000378 |
| mesh[22].descriptor_ui | D016176 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | metabolism |
| mesh[22].descriptor_name | T-Lymphocyte Subsets |
| mesh[23].qualifier_ui | Q000378 |
| mesh[23].descriptor_ui | D061026 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | metabolism |
| mesh[23].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[24].qualifier_ui | Q000378 |
| mesh[24].descriptor_ui | D016692 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | metabolism |
| mesh[24].descriptor_name | Receptors, Antigen, T-Cell, gamma-delta |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D020869 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Gene Expression Profiling |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D007167 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Immunotherapy |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D009369 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Neoplasms |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | Q000378 |
| mesh[29].descriptor_ui | D016176 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | metabolism |
| mesh[29].descriptor_name | T-Lymphocyte Subsets |
| mesh[30].qualifier_ui | Q000378 |
| mesh[30].descriptor_ui | D061026 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | metabolism |
| mesh[30].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[31].qualifier_ui | Q000378 |
| mesh[31].descriptor_ui | D016692 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | metabolism |
| mesh[31].descriptor_name | Receptors, Antigen, T-Cell, gamma-delta |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D020869 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Gene Expression Profiling |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D007167 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Immunotherapy |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D009369 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Neoplasms |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D006801 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Humans |
| mesh[36].qualifier_ui | Q000378 |
| mesh[36].descriptor_ui | D016176 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | metabolism |
| mesh[36].descriptor_name | T-Lymphocyte Subsets |
| mesh[37].qualifier_ui | Q000378 |
| mesh[37].descriptor_ui | D061026 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | metabolism |
| mesh[37].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[38].qualifier_ui | Q000378 |
| mesh[38].descriptor_ui | D016692 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | metabolism |
| mesh[38].descriptor_name | Receptors, Antigen, T-Cell, gamma-delta |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D020869 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Gene Expression Profiling |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D007167 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Immunotherapy |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D009369 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Neoplasms |
| type | article |
| title | PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy |
| awards[0].id | https://openalex.org/G7368717355 |
| awards[0].funder_id | https://openalex.org/F4320334626 |
| awards[0].display_name | |
| awards[0].funder_award_id | MR/K002627/1 |
| awards[0].funder_display_name | Medical Research Council |
| awards[1].id | https://openalex.org/G252200707 |
| awards[1].funder_id | https://openalex.org/F4320307874 |
| awards[1].display_name | |
| awards[1].funder_award_id | 220589/Z/20/Z |
| awards[1].funder_display_name | Wellcome |
| biblio.issue | 3 |
| biblio.volume | 5 |
| biblio.last_page | 432 |
| biblio.first_page | 420 |
| topics[0].id | https://openalex.org/T11020 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immune Cell Function and Interaction |
| topics[1].id | https://openalex.org/T10158 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Immunotherapy and Biomarkers |
| topics[2].id | https://openalex.org/T11491 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9994000196456909 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | CAR-T cell therapy research |
| funders[0].id | https://openalex.org/F4320307874 |
| funders[0].ror | https://ror.org/029chgv08 |
| funders[0].display_name | Wellcome |
| funders[1].id | https://openalex.org/F4320310465 |
| funders[1].ror | https://ror.org/04hjbmv12 |
| funders[1].display_name | Takeda Pharmaceutical Company |
| funders[2].id | https://openalex.org/F4320312060 |
| funders[2].ror | https://ror.org/04tnbqb63 |
| funders[2].display_name | Francis Crick Institute |
| funders[3].id | https://openalex.org/F4320334626 |
| funders[3].ror | https://ror.org/03x94j517 |
| funders[3].display_name | Medical Research Council |
| is_xpac | False |
| apc_list.value | 9750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 11690 |
| apc_paid.value | 9750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 11690 |
| concepts[0].id | https://openalex.org/C154317977 |
| concepts[0].level | 3 |
| concepts[0].score | 0.6705223321914673 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[0].display_name | Cytotoxic T cell |
| concepts[1].id | https://openalex.org/C2780674031 |
| concepts[1].level | 4 |
| concepts[1].score | 0.6031705737113953 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2012719 |
| concepts[1].display_name | Cancer immunotherapy |
| concepts[2].id | https://openalex.org/C2777658100 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5399087071418762 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q180614 |
| concepts[2].display_name | Melanoma |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5357185006141663 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2777701055 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5258027911186218 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[4].display_name | Immunotherapy |
| concepts[5].id | https://openalex.org/C167672396 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5016031265258789 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[5].display_name | CD8 |
| concepts[6].id | https://openalex.org/C96232424 |
| concepts[6].level | 3 |
| concepts[6].score | 0.48822811245918274 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q4118072 |
| concepts[6].display_name | Cancer cell |
| concepts[7].id | https://openalex.org/C51785407 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4831109046936035 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2627568 |
| concepts[7].display_name | Effector |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4763367772102356 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C19317047 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4758186936378479 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q412037 |
| concepts[9].display_name | T-cell receptor |
| concepts[10].id | https://openalex.org/C2781053074 |
| concepts[10].level | 4 |
| concepts[10].score | 0.46510371565818787 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q21100639 |
| concepts[10].display_name | PD-L1 |
| concepts[11].id | https://openalex.org/C162317418 |
| concepts[11].level | 4 |
| concepts[11].score | 0.4645054042339325 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q252857 |
| concepts[11].display_name | Transcriptome |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.455095499753952 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C2776090121 |
| concepts[13].level | 3 |
| concepts[13].score | 0.4520714581012726 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q193529 |
| concepts[13].display_name | T cell |
| concepts[14].id | https://openalex.org/C2780851360 |
| concepts[14].level | 4 |
| concepts[14].score | 0.42975935339927673 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[14].display_name | Immune checkpoint |
| concepts[15].id | https://openalex.org/C147483822 |
| concepts[15].level | 2 |
| concepts[15].score | 0.4100976884365082 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q103537 |
| concepts[15].display_name | Antigen |
| concepts[16].id | https://openalex.org/C95444343 |
| concepts[16].level | 1 |
| concepts[16].score | 0.3821810781955719 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[16].display_name | Cell biology |
| concepts[17].id | https://openalex.org/C203014093 |
| concepts[17].level | 1 |
| concepts[17].score | 0.3235727548599243 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[17].display_name | Immunology |
| concepts[18].id | https://openalex.org/C8891405 |
| concepts[18].level | 2 |
| concepts[18].score | 0.3122205138206482 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[18].display_name | Immune system |
| concepts[19].id | https://openalex.org/C104317684 |
| concepts[19].level | 2 |
| concepts[19].score | 0.14293330907821655 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[19].display_name | Gene |
| concepts[20].id | https://openalex.org/C150194340 |
| concepts[20].level | 3 |
| concepts[20].score | 0.13355320692062378 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[20].display_name | Gene expression |
| concepts[21].id | https://openalex.org/C54355233 |
| concepts[21].level | 1 |
| concepts[21].score | 0.12422171235084534 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[21].display_name | Genetics |
| concepts[22].id | https://openalex.org/C202751555 |
| concepts[22].level | 2 |
| concepts[22].score | 0.07551375031471252 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[22].display_name | In vitro |
| keywords[0].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[0].score | 0.6705223321914673 |
| keywords[0].display_name | Cytotoxic T cell |
| keywords[1].id | https://openalex.org/keywords/cancer-immunotherapy |
| keywords[1].score | 0.6031705737113953 |
| keywords[1].display_name | Cancer immunotherapy |
| keywords[2].id | https://openalex.org/keywords/melanoma |
| keywords[2].score | 0.5399087071418762 |
| keywords[2].display_name | Melanoma |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.5357185006141663 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/immunotherapy |
| keywords[4].score | 0.5258027911186218 |
| keywords[4].display_name | Immunotherapy |
| keywords[5].id | https://openalex.org/keywords/cd8 |
| keywords[5].score | 0.5016031265258789 |
| keywords[5].display_name | CD8 |
| keywords[6].id | https://openalex.org/keywords/cancer-cell |
| keywords[6].score | 0.48822811245918274 |
| keywords[6].display_name | Cancer cell |
| keywords[7].id | https://openalex.org/keywords/effector |
| keywords[7].score | 0.4831109046936035 |
| keywords[7].display_name | Effector |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.4763367772102356 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/t-cell-receptor |
| keywords[9].score | 0.4758186936378479 |
| keywords[9].display_name | T-cell receptor |
| keywords[10].id | https://openalex.org/keywords/pd-l1 |
| keywords[10].score | 0.46510371565818787 |
| keywords[10].display_name | PD-L1 |
| keywords[11].id | https://openalex.org/keywords/transcriptome |
| keywords[11].score | 0.4645054042339325 |
| keywords[11].display_name | Transcriptome |
| keywords[12].id | https://openalex.org/keywords/biology |
| keywords[12].score | 0.455095499753952 |
| keywords[12].display_name | Biology |
| keywords[13].id | https://openalex.org/keywords/t-cell |
| keywords[13].score | 0.4520714581012726 |
| keywords[13].display_name | T cell |
| keywords[14].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[14].score | 0.42975935339927673 |
| keywords[14].display_name | Immune checkpoint |
| keywords[15].id | https://openalex.org/keywords/antigen |
| keywords[15].score | 0.4100976884365082 |
| keywords[15].display_name | Antigen |
| keywords[16].id | https://openalex.org/keywords/cell-biology |
| keywords[16].score | 0.3821810781955719 |
| keywords[16].display_name | Cell biology |
| keywords[17].id | https://openalex.org/keywords/immunology |
| keywords[17].score | 0.3235727548599243 |
| keywords[17].display_name | Immunology |
| keywords[18].id | https://openalex.org/keywords/immune-system |
| keywords[18].score | 0.3122205138206482 |
| keywords[18].display_name | Immune system |
| keywords[19].id | https://openalex.org/keywords/gene |
| keywords[19].score | 0.14293330907821655 |
| keywords[19].display_name | Gene |
| keywords[20].id | https://openalex.org/keywords/gene-expression |
| keywords[20].score | 0.13355320692062378 |
| keywords[20].display_name | Gene expression |
| keywords[21].id | https://openalex.org/keywords/genetics |
| keywords[21].score | 0.12422171235084534 |
| keywords[21].display_name | Genetics |
| keywords[22].id | https://openalex.org/keywords/in-vitro |
| keywords[22].score | 0.07551375031471252 |
| keywords[22].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1038/s43018-023-00690-0 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210236562 |
| locations[0].source.issn | 2662-1347 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2662-1347 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nature Cancer |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s43018-023-00690-0.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nature Cancer |
| locations[0].landing_page_url | https://doi.org/10.1038/s43018-023-00690-0 |
| locations[1].id | pmid:38172341 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Nature cancer |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38172341 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10965442 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10965442/pdf/43018_2023_Article_690.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Nat Cancer |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10965442 |
| locations[3].id | pmh:oai:figshare.com:article/25450303 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400572 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[3].source.host_organization | https://openalex.org/I196829312 |
| locations[3].source.host_organization_name | La Trobe University |
| locations[3].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[3].license | cc-by |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Journal contribution |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://figshare.com/articles/journal_contribution/PD-1_defines_a_distinct_functional_tissue-adapted_state_in_V_1_T_cells_with_implications_for_cancer_immunotherapy_/25450303 |
| locations[4].id | pmh:oai:kclpure.kcl.ac.uk:publications/9405de07-8435-4186-9e58-960647bd0116 |
| locations[4].is_oa | True |
| locations[4].source | |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Davies , D , Kamdar , S , Woolf , R , Zlatareva , I , Iannitto , M L , Morton , C , Haque , Y , Martin , H , Biswas , D , Ndagire , S , Munonyara , M , Gillett , C , O’Neill , O , Nussbaumer , O , Hayday , A & Wu , Y 2024 , ' PD-1 defines a distinct, functional, tissue-adapted state in Vδ1 + T cells with implications for cancer immunotherapy ' , Nature Cancer , vol. 5 , no. 3 , pp. 420-432 . https://doi.org/10.1038/s43018-023-00690-0 |
| locations[4].landing_page_url | https://kclpure.kcl.ac.uk/portal/en/publications/9405de07-8435-4186-9e58-960647bd0116 |
| locations[5].id | doi:10.25418/crick.25450303.v1 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S7407051354 |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | The Francis Crick Institute |
| locations[5].source.host_organization | |
| locations[5].source.host_organization_name | |
| locations[5].license | cc-by |
| locations[5].pdf_url | |
| locations[5].version | |
| locations[5].raw_type | article-journal |
| locations[5].license_id | https://openalex.org/licenses/cc-by |
| locations[5].is_accepted | False |
| locations[5].is_published | |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | https://doi.org/10.25418/crick.25450303.v1 |
| indexed_in | crossref, datacite, pubmed |
| authorships[0].author.id | https://openalex.org/A5101871931 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-7161-5331 |
| authorships[0].author.display_name | Daniel Davies |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[0].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I183935753 |
| authorships[0].affiliations[1].raw_affiliation_string | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK. |
| authorships[0].institutions[0].id | https://openalex.org/I183935753 |
| authorships[0].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | King's College London |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Daniel Davies |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK., Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[1].author.id | https://openalex.org/A5034738625 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2689-9723 |
| authorships[1].author.display_name | Shraddha Kamdar |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[1].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I183935753 |
| authorships[1].affiliations[1].raw_affiliation_string | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK. |
| authorships[1].institutions[0].id | https://openalex.org/I183935753 |
| authorships[1].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | King's College London |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Shraddha Kamdar |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK., Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[2].author.id | https://openalex.org/A5052206614 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3200-0075 |
| authorships[2].author.display_name | Richard Woolf |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1298207432 |
| authorships[2].affiliations[0].raw_affiliation_string | St. John's Institute of Dermatology, Guy's Hospital, London, UK. |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I183935753 |
| authorships[2].affiliations[1].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[2].institutions[0].id | https://openalex.org/I1298207432 |
| authorships[2].institutions[0].ror | https://ror.org/04r33pf22 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1298207432, https://openalex.org/I200166805, https://openalex.org/I4210111135 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | Guy's Hospital |
| authorships[2].institutions[1].id | https://openalex.org/I183935753 |
| authorships[2].institutions[1].ror | https://ror.org/0220mzb33 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[2].institutions[1].country_code | GB |
| authorships[2].institutions[1].display_name | King's College London |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Richard Woolf |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Peter Gorer Department of Immunobiology, King's College London, London, UK., St. John's Institute of Dermatology, Guy's Hospital, London, UK. |
| authorships[3].author.id | https://openalex.org/A5082427195 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8027-8042 |
| authorships[3].author.display_name | Iva Zlatareva |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[3].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[3].institutions[0].id | https://openalex.org/I183935753 |
| authorships[3].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | King's College London |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Iva Zlatareva |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[4].author.id | https://openalex.org/A5091151527 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Maria Luisa Iannitto |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[4].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[4].institutions[0].id | https://openalex.org/I183935753 |
| authorships[4].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | King's College London |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Maria Luisa Iannitto |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[5].author.id | https://openalex.org/A5027899755 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1912-2636 |
| authorships[5].author.display_name | Cienne Morton |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[5].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I1298207432 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Medical Oncology, Guy's Hospital, London, UK. |
| authorships[5].institutions[0].id | https://openalex.org/I1298207432 |
| authorships[5].institutions[0].ror | https://ror.org/04r33pf22 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1298207432, https://openalex.org/I200166805, https://openalex.org/I4210111135 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | Guy's Hospital |
| authorships[5].institutions[1].id | https://openalex.org/I183935753 |
| authorships[5].institutions[1].ror | https://ror.org/0220mzb33 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[5].institutions[1].country_code | GB |
| authorships[5].institutions[1].display_name | King's College London |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Cienne Morton |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medical Oncology, Guy's Hospital, London, UK., Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[6].author.id | https://openalex.org/A5090204284 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Yasmin Haque |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[6].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[6].institutions[0].id | https://openalex.org/I183935753 |
| authorships[6].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | King's College London |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yasmin Haque |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[7].author.id | https://openalex.org/A5051383178 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-6932-9312 |
| authorships[7].author.display_name | H Martin |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2801081054 |
| authorships[7].affiliations[0].raw_affiliation_string | Immunosurveillance Laboratory, Francis Crick Institute, London, UK. |
| authorships[7].institutions[0].id | https://openalex.org/I2801081054 |
| authorships[7].institutions[0].ror | https://ror.org/04tnbqb63 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I2801081054 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | The Francis Crick Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Hannah Martin |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Immunosurveillance Laboratory, Francis Crick Institute, London, UK. |
| authorships[8].author.id | https://openalex.org/A5048953598 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9141-5188 |
| authorships[8].author.display_name | Dhruva Biswas |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210153400 |
| authorships[8].affiliations[0].raw_affiliation_string | Academic Foundation Programme, King's College Hospital, London, UK. |
| authorships[8].institutions[0].id | https://openalex.org/I4210153400 |
| authorships[8].institutions[0].ror | https://ror.org/044nptt90 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210111135, https://openalex.org/I4210153400 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | King's College Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Dhruva Biswas |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Academic Foundation Programme, King's College Hospital, London, UK. |
| authorships[9].author.id | https://openalex.org/A5093644360 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Susan Ndagire |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1298207432, https://openalex.org/I4210113441 |
| authorships[9].affiliations[0].raw_affiliation_string | King's Health Partners Cancer Biobank, Guy's Hospital, London, UK. |
| authorships[9].institutions[0].id | https://openalex.org/I1298207432 |
| authorships[9].institutions[0].ror | https://ror.org/04r33pf22 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1298207432, https://openalex.org/I200166805, https://openalex.org/I4210111135 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | Guy's Hospital |
| authorships[9].institutions[1].id | https://openalex.org/I4210113441 |
| authorships[9].institutions[1].ror | https://ror.org/01xcsye48 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210113441 |
| authorships[9].institutions[1].country_code | GB |
| authorships[9].institutions[1].display_name | Kings Health Partners |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Susan Ndagire |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | King's Health Partners Cancer Biobank, Guy's Hospital, London, UK. |
| authorships[10].author.id | https://openalex.org/A5001102364 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-2740-2504 |
| authorships[10].author.display_name | Martina Munonyara |
| authorships[10].countries | GB |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1324925910 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Cellular Pathology, St. Thomas' Hospital, London, UK. |
| authorships[10].institutions[0].id | https://openalex.org/I1324925910 |
| authorships[10].institutions[0].ror | https://ror.org/054gk2851 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I1324925910, https://openalex.org/I200166805, https://openalex.org/I4210111135 |
| authorships[10].institutions[0].country_code | GB |
| authorships[10].institutions[0].display_name | St Thomas' Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Martina Munonyara |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Cellular Pathology, St. Thomas' Hospital, London, UK. |
| authorships[11].author.id | https://openalex.org/A5055450638 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-3643-4057 |
| authorships[11].author.display_name | Cheryl Gillett |
| authorships[11].countries | GB |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1298207432, https://openalex.org/I4210113441 |
| authorships[11].affiliations[0].raw_affiliation_string | King's Health Partners Cancer Biobank, Guy's Hospital, London, UK. |
| authorships[11].institutions[0].id | https://openalex.org/I1298207432 |
| authorships[11].institutions[0].ror | https://ror.org/04r33pf22 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I1298207432, https://openalex.org/I200166805, https://openalex.org/I4210111135 |
| authorships[11].institutions[0].country_code | GB |
| authorships[11].institutions[0].display_name | Guy's Hospital |
| authorships[11].institutions[1].id | https://openalex.org/I4210113441 |
| authorships[11].institutions[1].ror | https://ror.org/01xcsye48 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210113441 |
| authorships[11].institutions[1].country_code | GB |
| authorships[11].institutions[1].display_name | Kings Health Partners |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Cheryl Gillett |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | King's Health Partners Cancer Biobank, Guy's Hospital, London, UK. |
| authorships[12].author.id | https://openalex.org/A5108891132 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Olga O’Neill |
| authorships[12].countries | GB |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I2801081054 |
| authorships[12].affiliations[0].raw_affiliation_string | Advanced Sequencing Facility, Francis Crick Institute, London, UK. |
| authorships[12].institutions[0].id | https://openalex.org/I2801081054 |
| authorships[12].institutions[0].ror | https://ror.org/04tnbqb63 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I2801081054 |
| authorships[12].institutions[0].country_code | GB |
| authorships[12].institutions[0].display_name | The Francis Crick Institute |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Olga O'Neill |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Advanced Sequencing Facility, Francis Crick Institute, London, UK. |
| authorships[13].author.id | https://openalex.org/A5012957914 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-4017-0990 |
| authorships[13].author.display_name | Oliver Nussbaumer |
| authorships[13].countries | GB |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[13].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[13].institutions[0].id | https://openalex.org/I183935753 |
| authorships[13].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[13].institutions[0].country_code | GB |
| authorships[13].institutions[0].display_name | King's College London |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Oliver Nussbaumer |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Peter Gorer Department of Immunobiology, King's College London, London, UK. |
| authorships[14].author.id | https://openalex.org/A5090249459 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-9495-5793 |
| authorships[14].author.display_name | Adrian Hayday |
| authorships[14].countries | GB |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[14].affiliations[0].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. [email protected]. |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I2801081054 |
| authorships[14].affiliations[1].raw_affiliation_string | Immunosurveillance Laboratory, Francis Crick Institute, London, UK. [email protected]. |
| authorships[14].affiliations[2].institution_ids | https://openalex.org/I183935753 |
| authorships[14].affiliations[2].raw_affiliation_string | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK. [email protected]. |
| authorships[14].institutions[0].id | https://openalex.org/I183935753 |
| authorships[14].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[14].institutions[0].country_code | GB |
| authorships[14].institutions[0].display_name | King's College London |
| authorships[14].institutions[1].id | https://openalex.org/I2801081054 |
| authorships[14].institutions[1].ror | https://ror.org/04tnbqb63 |
| authorships[14].institutions[1].type | facility |
| authorships[14].institutions[1].lineage | https://openalex.org/I2801081054 |
| authorships[14].institutions[1].country_code | GB |
| authorships[14].institutions[1].display_name | The Francis Crick Institute |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Adrian Hayday |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK. [email protected]., Immunosurveillance Laboratory, Francis Crick Institute, London, UK. [email protected]., Peter Gorer Department of Immunobiology, King's College London, London, UK. [email protected]. |
| authorships[15].author.id | https://openalex.org/A5048086477 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-4080-3935 |
| authorships[15].author.display_name | Yin Wu |
| authorships[15].countries | GB |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1298207432 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Guy's Hospital, London, UK. [email protected]. |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I183935753 |
| authorships[15].affiliations[1].raw_affiliation_string | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK. [email protected]. |
| authorships[15].affiliations[2].institution_ids | https://openalex.org/I183935753 |
| authorships[15].affiliations[2].raw_affiliation_string | Peter Gorer Department of Immunobiology, King's College London, London, UK. [email protected]. |
| authorships[15].institutions[0].id | https://openalex.org/I1298207432 |
| authorships[15].institutions[0].ror | https://ror.org/04r33pf22 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I1298207432, https://openalex.org/I200166805, https://openalex.org/I4210111135 |
| authorships[15].institutions[0].country_code | GB |
| authorships[15].institutions[0].display_name | Guy's Hospital |
| authorships[15].institutions[1].id | https://openalex.org/I183935753 |
| authorships[15].institutions[1].ror | https://ror.org/0220mzb33 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[15].institutions[1].country_code | GB |
| authorships[15].institutions[1].display_name | King's College London |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Yin Wu |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK. [email protected]., Department of Medical Oncology, Guy's Hospital, London, UK. [email protected]., Peter Gorer Department of Immunobiology, King's College London, London, UK. [email protected]. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s43018-023-00690-0.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2024-01-04T00:00:00 |
| display_name | PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11020 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immune Cell Function and Interaction |
| related_works | https://openalex.org/W4283274326, https://openalex.org/W2608950674, https://openalex.org/W2839753868, https://openalex.org/W4384207630, https://openalex.org/W4362464765, https://openalex.org/W4242864454, https://openalex.org/W2921651111, https://openalex.org/W2187430385, https://openalex.org/W2916292904, https://openalex.org/W2807981861 |
| cited_by_count | 38 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 22 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 15 |
| locations_count | 6 |
| best_oa_location.id | doi:10.1038/s43018-023-00690-0 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210236562 |
| best_oa_location.source.issn | 2662-1347 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2662-1347 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nature Cancer |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s43018-023-00690-0.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nature Cancer |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s43018-023-00690-0 |
| primary_location.id | doi:10.1038/s43018-023-00690-0 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210236562 |
| primary_location.source.issn | 2662-1347 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2662-1347 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nature Cancer |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s43018-023-00690-0.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nature Cancer |
| primary_location.landing_page_url | https://doi.org/10.1038/s43018-023-00690-0 |
| publication_date | 2024-01-03 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2133075384, https://openalex.org/W3217126890, https://openalex.org/W2949375297, https://openalex.org/W3043703771, https://openalex.org/W2039123767, https://openalex.org/W2899145148, https://openalex.org/W2506616866, https://openalex.org/W2979874482, https://openalex.org/W3196420804, https://openalex.org/W2980303761, https://openalex.org/W3125831681, https://openalex.org/W4220656480, https://openalex.org/W4315641892, https://openalex.org/W4327568900, https://openalex.org/W4313888795, https://openalex.org/W2152061559, https://openalex.org/W2766209631, https://openalex.org/W2765417948, https://openalex.org/W2924359886, https://openalex.org/W3131658494, https://openalex.org/W4316927247, https://openalex.org/W1107917109, https://openalex.org/W4281779271, https://openalex.org/W4380480712, https://openalex.org/W2761586559, https://openalex.org/W2097995306, https://openalex.org/W2045500037, https://openalex.org/W1571249274, https://openalex.org/W2126804376, https://openalex.org/W2299181842, https://openalex.org/W2761575992, https://openalex.org/W2887187316, https://openalex.org/W2991341799, https://openalex.org/W3205534424, https://openalex.org/W4281739379, https://openalex.org/W4384925429, https://openalex.org/W2113765099, https://openalex.org/W4384305930, https://openalex.org/W2809205318, https://openalex.org/W2976924121, https://openalex.org/W3138260539, https://openalex.org/W2754079107, https://openalex.org/W2336322268, https://openalex.org/W1987337968, https://openalex.org/W2501293727, https://openalex.org/W3217337235, https://openalex.org/W3194116827, https://openalex.org/W4323043053, https://openalex.org/W4386926153, https://openalex.org/W2975736685, https://openalex.org/W2561322596, https://openalex.org/W2774781355, https://openalex.org/W2950341312, https://openalex.org/W1978436252, https://openalex.org/W1933645290, https://openalex.org/W2097855813, https://openalex.org/W2522313999, https://openalex.org/W2028433016, https://openalex.org/W3106704421, https://openalex.org/W2421681513, https://openalex.org/W3154371246, https://openalex.org/W2527905628, https://openalex.org/W2125616358, https://openalex.org/W3174672654, https://openalex.org/W4213208131, https://openalex.org/W2273021913, https://openalex.org/W4313342461, https://openalex.org/W1968697332, https://openalex.org/W3047400464, https://openalex.org/W2615301036, https://openalex.org/W2890056446, https://openalex.org/W2912741252, https://openalex.org/W3039554804, https://openalex.org/W4210589143, https://openalex.org/W2297563260, https://openalex.org/W2052356932, https://openalex.org/W4226258201, https://openalex.org/W2753432434 |
| referenced_works_count | 78 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99020047 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |